Speciality chemicals and vitamins group DSM on Wednesday announced ‘another strong year’ and an increased dividend over 2011, with a ‘cautiously optimistic’ outlook for 2012.

Full year operating profit from continuing operations increased 12% to €1.3bn, the company said. Total revenue rose 11% to over €9bn while net profit climbed 61% to €814m.
‘We are conscious that risks to the macro-economic global outlook remain, and that weakness persists in Europe and some of our end markets, especially building and construction,’ said chief executive Feike Sijbesma in a statement. Nevertheless, the company is well-positioned to reach its ‘ambitious’ 2013 targets, Sijbesma said.